114 related articles for article (PubMed ID: 20439394)
1. The pharmacogenetics of depression: enter the GWAS.
Malhotra AK
Am J Psychiatry; 2010 May; 167(5):493-5. PubMed ID: 20439394
[No Abstract] [Full Text] [Related]
2. Pharmacogenomics of antidepressant drugs.
Horstmann S; Binder EB
Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association studies in pharmacogenomics of antidepressants.
Lin E; Lane HY
Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
[TBL] [Abstract][Full Text] [Related]
4. Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment: can computational intelligence be used to augment clinical assessments?
Athreya AP; Iyer R; Wang L; Weinshilboum RM; Bobo WV
Pharmacogenomics; 2019 Sep; 20(14):983-988. PubMed ID: 31559920
[No Abstract] [Full Text] [Related]
5. [Current state and potential of pharmacogenetic studies in the treatment of depression].
Ivanets NN; Tikhonova YG; Kinkulkina MA; Avdeeva TI
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):113-121. PubMed ID: 26171487
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association studies of antidepressant outcome: a brief review.
Laje G; McMahon FJ
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1553-7. PubMed ID: 21115088
[TBL] [Abstract][Full Text] [Related]
7. From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.
Fabbri C; Porcelli S; Serretti A
Can J Psychiatry; 2014 Feb; 59(2):62-75. PubMed ID: 24881125
[TBL] [Abstract][Full Text] [Related]
8. The role of pharmacogenetics in the treatment of depression and anxiety disorders.
Schosser A; Kasper S
Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.
Narasimhan S; Lohoff FW
Pharmacogenomics; 2012 Mar; 13(4):441-64. PubMed ID: 22380000
[TBL] [Abstract][Full Text] [Related]
10. Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes.
Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Montgomery S; Noro M; Oswald P; Snyder L; Souery D; Zohar J; Mendlewicz J
World J Biol Psychiatry; 2010 Dec; 11(8):985-90. PubMed ID: 20822372
[TBL] [Abstract][Full Text] [Related]
11. Association of catechol-O-methyltransferase variants with duloxetine response in major depressive disorder.
Houston JP; Kohler J; Ostbye KM; Heinloth A; Perlis RH
Psychiatry Res; 2011 Oct; 189(3):475-7. PubMed ID: 21788083
[TBL] [Abstract][Full Text] [Related]
12. Restoring value to stalled Phase II compounds: the case for developing a novel compound for depression using pharmacogenetics.
Reed C; Kalnik M; Rakin K; Athanasiou M; Judson R
Pharmacogenomics; 2005 Mar; 6(2):95-100. PubMed ID: 15882128
[No Abstract] [Full Text] [Related]
13. The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depression.
Jann MW; Cohen LJ
Drug Metabol Drug Interact; 2000; 16(1):39-67. PubMed ID: 10820582
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacogenetics of depression in elderly patients].
Monnin J; Haffen E; Sechter D; Vandel P
Psychol Neuropsychiatr Vieil; 2009 Mar; 7(1):43-55. PubMed ID: 19251571
[TBL] [Abstract][Full Text] [Related]
15. Genetic studies of drug response and side effects in the STAR*D study, part 1.
Garriock HA; Hamilton SP
J Clin Psychiatry; 2009 Aug; 70(8):1186-7. PubMed ID: 19758527
[No Abstract] [Full Text] [Related]
16. Pharmacogenetics in the treatment of depression: pharmacodynamic studies.
Serretti A; Artioli P; Quartesan R
Pharmacogenet Genomics; 2005 Feb; 15(2):61-7. PubMed ID: 15861029
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic studies of depression.
Henn FA
Biol Psychiatry; 2008 Jun; 63(12):1101-2. PubMed ID: 18514642
[No Abstract] [Full Text] [Related]
18. Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression.
Domschke K; Dannlowski U; Hohoff C; Ohrmann P; Bauer J; Kugel H; Zwanzger P; Heindel W; Deckert J; Arolt V; Suslow T; Baune BT
Eur Neuropsychopharmacol; 2010 May; 20(5):301-9. PubMed ID: 19854625
[TBL] [Abstract][Full Text] [Related]
19. Dialogues in clinical neuroscience. Remission in depression.
Naber D
Dialogues Clin Neurosci; 2008; 10(4):369-70. PubMed ID: 19170393
[No Abstract] [Full Text] [Related]
20. Genetic studies of drug response and side effects in the STAR*D study, part 2.
Garriock HA; Hamilton SP
J Clin Psychiatry; 2009 Sep; 70(9):1323-5. PubMed ID: 19818256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
